Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
Open Access
- 1 March 2014
- journal article
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 31 (1) , 79-83
Abstract
Three cases of Epstein-Barr virus (EBV)-negative post-transplant lymphoproliferative disease that occurred 6 to 8 years after renal transplantation are reported. The patients respectively had gastric mucosa-associated lymphoid tissue lymphoma, gastric diffuse large B-cell lymphoma, and atypical Burkitt lymphoma. Absence of EBV in the tissue samples was demonstrated by both in situ hybridization for EBV early RNA and polymerase chain reaction for EBV DNA. Patients were treated with reduction in immunosuppression and combined chemotherapy plus an anti-CD20 monoclonal antibody, rituximab. Despite the reduction in immunosuppression, patients had stable renal functions without loss of graft functions. The patient with atypical Burkitt lymphoma had an abnormal karyotype, did not respond to treatment completely, and died due to disease progression. The other patients are still alive and in remission 5 and 3 years after diagnosis, respectively. EBV-negative post-transplant lymphoproliferative diseases are usually late-onset and are reported to have poor prognosis. Thus, reduction in immunosuppression is usually not sufficient for treatment and more aggressive approaches like rituximab with combined chemotherapy are required.\uKeywords
This publication has 28 references indexed in Scilit:
- Anthracycline-based Chemotherapy as First-line Treatment in Adults with Malignant Posttransplant Lymphoproliferative Disorder after Solid Organ TransplantationTransplantation, 2006
- Management of patients with post-transplant lymphoproliferative disorder: the role of rituximabTransplant International, 2006
- Prognostic Analysis for Survival in Adult Solid Organ Transplant Recipients With Post-Transplantation Lymphoproliferative DisordersJournal of Clinical Oncology, 2005
- Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantationCancer, 2005
- Epstein-Barr Virus and CancerClinical Cancer Research, 2004
- Burkitt Lymphoma Arising in Organ Transplant RecipientsAmerican Journal of Surgical Pathology, 2003
- Long-term survival of renal graft complicated with Burkitt lymphomaPediatric Nephrology, 2002
- Incidence and clinical course of de-novo malignancies in renal allograft recipientsEuropean Journal of Surgical Oncology, 2001
- EPSTEIN-BARR VIRUS-NEGATIVE LYMPHOPROLIFERATIVE DISORDERS IN LONG-TERM SURVIVORS AFTER HEART, KIDNEY, AND LIVER TRANSPLANT1Transplantation, 2000
- Disseminated Burkitt's Lymphoma After Kidney Transplantation: A Case Report in a Boy with Drash SyndromeJournal of Pediatric Hematology/Oncology, 1997